|
Market Closed -
Nasdaq
23:00:00 12/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.260 USD | -1.74% |
|
-3.42% | +9.71% |
| 07-31 | Cerus Corporation, Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Cerus Corporation Revises Earnings Guidance for the Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Devices & Implants
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 464M | - | - | - | ||
| 172B | |||||
| 113B | |||||
| 106B | |||||
| 75.31B | |||||
| 61.8B |
- Stock Market
- Stocks
- CERS Stock
- Charts Cerus Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
